These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3524148)

  • 1. The mechanisms of cartilage catabolism.
    Dingle JT
    Agents Actions Suppl; 1986; 18():31-7. PubMed ID: 3524148
    [No Abstract]   [Full Text] [Related]  

  • 2. Mononuclear cell factor modulates the concomitant release of proteoglycan and latent proteinase by human articular cartilage in organ culture.
    Campbell IK; Mort JS; Golds EE; Roughley PJ
    Agents Actions Suppl; 1986; 18():43-6. PubMed ID: 3524149
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of interleukin-1beta on chondroblast viability and extracellular matrix changes in bovine articular cartilage explants.
    Stabellini G; De Mattei M; Calastrini C; Gagliano N; Moscheni C; Pasello M; Pellati A; Bellucci C; Gioia M
    Biomed Pharmacother; 2003 Sep; 57(7):314-9. PubMed ID: 14499180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible role of synovial factors in cartilage destruction.
    Crossley MJ; Connon AM; Hunneyball IM
    Agents Actions Suppl; 1986; 18():39-42. PubMed ID: 3014846
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
    Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.
    Sztrolovics R; White RJ; Roughley PJ; Mort JS
    Biochem J; 2002 Mar; 362(Pt 2):465-72. PubMed ID: 11853556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
    Wang J; Elewaut D; Veys EM; Verbruggen G
    Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro.
    Rainsford KD
    J Pharm Pharmacol; 1986 Nov; 38(11):829-33. PubMed ID: 2879013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity of synthesis of human cartilage matrix to inhibition by IL-1 suggests a mechanism for the development of osteoarthritis.
    Dingle JT; Horner A; Shield M
    Cell Biochem Funct; 1991 Apr; 9(2):99-102. PubMed ID: 1934316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1beta-stimulated catabolism.
    Sztrolovics R; Recklies AD; Roughley PJ; Mort JS
    Biochem J; 2002 Mar; 362(Pt 2):473-9. PubMed ID: 11853557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The degradation of cartilage matrix by an intracellular protease.
    Ali SY
    Biochem J; 1964 Dec; 93(3):611-8. PubMed ID: 5839195
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions.
    Malemud CJ; Martel-Pelletier J; Pelletier JP
    J Rheumatol; 1987 May; 14 Spec No():20-2. PubMed ID: 3305934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin is a potent inhibitor of interleukin 1 induced cartilage proteoglycan resorption in-vitro.
    Rainsford KD
    J Pharm Pharmacol; 1989 Jan; 41(1):60-3. PubMed ID: 2565969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic degradation of ossifying cartilage matrix and the removal of acid mucopolysaccharides prior to bone formation.
    Jibril AO
    Biochim Biophys Acta; 1967 Feb; 136(1):162-5. PubMed ID: 4226655
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of proteins from human synovium and mononuclear leucocytes that induce resorption of cartilage proteoglycan in vitro.
    Saklatvala J; Sarsfield SJ; Pilsworth LM
    Biochem J; 1983 Feb; 209(2):337-44. PubMed ID: 6847621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix loss in chondrocytes after exposure to interleukin-1β in NADPH oxidase-dependent manner.
    Funato S; Yasuhara R; Yoshimura K; Miyamoto Y; Kaneko K; Suzawa T; Chikazu D; Mishima K; Baba K; Kamijo R
    Cell Tissue Res; 2017 Apr; 368(1):135-144. PubMed ID: 28070636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1.
    MacDonald MH; Stover SM; Willits NH; Benton HP
    Am J Vet Res; 1992 Dec; 53(12):2278-85. PubMed ID: 1476308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interleukin 1 mediates cartilage matrix degradation.
    Krakauer T; Oppenheim JJ; Jasin HE
    Cell Immunol; 1985 Mar; 91(1):92-9. PubMed ID: 3871667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium.
    Yodlowski ML; Hubbard JR; Kispert J; Keller K; Sledge CB; Steinberg JJ
    J Rheumatol; 1990 Dec; 17(12):1600-7. PubMed ID: 2084232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1.
    Fujisawa T; Hattori T; Takahashi K; Kuboki T; Yamashita A; Takigawa M
    J Biochem; 1999 May; 125(5):966-75. PubMed ID: 10220591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.